In a recent study, we discovered that PAK4 regulates the transcriptional activity of CREB and thereby promotes prostate cancer progression through such mechanisms as the emergence of drug resistance and neuroendocrine differentiation21. Here, CREB1 is linked to prostate carcinoma.